Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Raltitrexed. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS known ✓ | P04818 | 9/20 | 0.98 |
| ▸ | DHFR | P00374 | 1/20 | 0.98 |
| ▸ | FOLR2 | P14207 | 1/20 | 0.98 |
| ▸ | FOLR1 | P15328 | 1/20 | 0.98 |
| ▸ | SLC19A1 | P41440 | 1/20 | 0.98 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.98 |
| ▸ | SLC46A1 | Q96NT5 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Raltitrexed SCHEMBL28154699 | 1.00 | TYMS (0.98) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL28155448 | 1.00 | TYMS (0.98) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL28369835 | 0.99 | TYMS (0.97) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL29490413 | 0.99 | TYMS (1.00) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL7438 | 0.99 | TYMS (1.00) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL13959 | 0.99 | TYMS (1.00) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL6240639 | 0.99 | TYMS (1.00) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL12078376 | 0.99 | TYMS (1.00) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL21248507 | 0.98 | TYMS (0.98) | TYMSDHFRFOLR2FOLR1SLC19A1 | |
| Raltitrexed SCHEMBL28384446 | 0.98 | TYMS (0.98) | TYMSDHFRFOLR2FOLR1SLC19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150087605-A1 | Compositions and Methods Comprising Carboxylic Acid-Containing Small Molecules | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2015-03-26 | — | — | US | claimed |
| CN-106957312-B | Raltitrexed hydrate crystal forms and preparation method thereof | NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. (CN) | 2019-11-01 | — | — | CN | disclosed |
| CN-106957311-A | Solvate of Raltitrexed and preparation method thereof | 南京正大天晴制药有限公司 | 2017-07-18 | — | — | CN | disclosed |
| CN-106957311-A | Solvate of Raltitrexed and preparation method thereof | 南京正大天晴制药有限公司 | 2017-07-18 | — | — | CN | disclosed |
| CN-106957312-A | Raltitrexed hydrate crystal forms and preparation method thereof | 南京正大天晴制药有限公司 | 2017-07-18 | — | — | CN | disclosed |
| US-20150087605-A1 | Compositions and Methods Comprising Carboxylic Acid-Containing Small Molecules | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2015-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087605-A1 | Compositions and Methods Comprising Carboxylic Acid-Containing Small Molecules | ANTXR2, AADAC, HAAO | TYMS 3475/4885DHFR 1134/4885FOLR2 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.